Skip to content
2000
  • ISSN: 1568-010X
  • E-ISSN: 1568-010X

Abstract

Despite the advanced and increasing understanding of the pathophysiology of asthma and other allergic diseases, current treatment remains unspecific and targets late events within the allergic cascade. Therefore, a novel and promising approach to treat allergic asthma is antagonizing IgE by anti-IgE antibodies. This review analyzes the role of IgE for the pathology of asthma, summarize the current data about action, safety and efficacy of anti-IgE therapy, and tries to give a rational approach for future indications and directions of treatment with anti-IgE antibodies.

Loading

Article metrics loading...

/content/journals/cdtia/10.2174/156801005774322162
2005-10-01
2025-06-26
Loading full text...

Full text loading...

/content/journals/cdtia/10.2174/156801005774322162
Loading

  • Article Type:
    Review Article
Keyword(s): allergic rhinitis; anti-Ige; asthma; atopy; monoclonal antibody; treatment
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test